ACHV - Achieve Life Sciences GAAP EPS of -$0.80 in-line
Achieve Life Sciences press release (NASDAQ:ACHV): Q1 GAAP EPS of -$0.80 in-line. As of March 31, 2022, the company’s cash, cash equivalents, and restricted cash was $36.4 million.
For further details see:
Achieve Life Sciences GAAP EPS of -$0.80 in-line